Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

0.33USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$0.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,509
52-wk High
$0.82
52-wk Low
$0.30

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

16 Jan 2018

Competitors

Earnings vs. Estimates